Table 2.
Distributions of first trimester specific gravity standardized urinary phthalate metabolite concentrations among MIREC study participants (n = 1857) in Canada, 2008–2011, including geometric means from Canadian Health Measures Survey 2009–2011 and Watkins et al. (2016) for comparison purpose
| Phthalates (μg/L) | LOD | %>LOD MIREC |
GM1 MIREC |
Min | 5th | 25th | 50th | 75th | 95th | Max | GM CHMS2 |
GM Watkins3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MBP | 0.2 | 99.8 | 13.5 | 0.1 | 4.1 | 8.5 | 13.0 | 20.8 | 47.7 | 1831.8 | - | 6.4 |
| MBzP | 0.2 | 99.5 | 6.1 | 0.1 | 1.5 | 3.1 | 5.6 | 11.2 | 37.3 | 342.7 | 8.2 | 3.0 |
| MCPP | 0.2 | 84.8 | 1.1 | 0.0 | 0.2 | 0.6 | 1.0 | 1.8 | 7.5 | 186.3 | 1.9 | 1.9 |
| MEHHP | 0.4 | 99.4 | 10.8 | 0.1 | 3.1 | 6.4 | 9.8 | 16.3 | 52.1 | 1114.3 | 12.0 | 7.2 |
| MEHP | 0.2 | 98.5 | 2.6 | 0.1 | 0.8 | 1.5 | 2.4 | 4.1 | 13.0 | 260.0 | 1.8 | 2.0 |
| MEOHP | 0.2 | 99.7 | 7.5 | 0.1 | 2.4 | 4.6 | 6.9 | 11.1 | 31.4 | 733.6 | 7.3 | 3.5 |
| MEP | 0.5 | 99.9 | 37.8 | 0.1 | 5.7 | 13.5 | 31.1 | 86.3 | 478.2 | 20,800.0 | 44.0 | 30.5 |
| ΣDEHP (μmol/L) | - | - | 0.07 | 0.00 | 0.02 | 0.04 | 0.07 | 0.11 | 0.33 | 7.22 | - | 0.07 |